KR100242397B1 - 트리아졸 유도체와 그의 염,그들의 제조방법 및 그들을 함유한 항진균제 - Google Patents
트리아졸 유도체와 그의 염,그들의 제조방법 및 그들을 함유한 항진균제 Download PDFInfo
- Publication number
- KR100242397B1 KR100242397B1 KR1019920023597A KR920023597A KR100242397B1 KR 100242397 B1 KR100242397 B1 KR 100242397B1 KR 1019920023597 A KR1019920023597 A KR 1019920023597A KR 920023597 A KR920023597 A KR 920023597A KR 100242397 B1 KR100242397 B1 KR 100242397B1
- Authority
- KR
- South Korea
- Prior art keywords
- group
- substituted
- unsubstituted
- alkyl
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP91-350318 | 1991-12-09 | ||
| JP35031891 | 1991-12-09 | ||
| JP92-293961 | 1992-10-08 | ||
| JP29396192A JP3471831B2 (ja) | 1991-12-09 | 1992-10-08 | 新規なトリアゾール誘導体およびその塩 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR100242397B1 true KR100242397B1 (ko) | 2000-03-02 |
Family
ID=26559630
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019920023597A Expired - Fee Related KR100242397B1 (ko) | 1991-12-09 | 1992-12-08 | 트리아졸 유도체와 그의 염,그들의 제조방법 및 그들을 함유한 항진균제 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US5366989A (https=) |
| EP (1) | EP0546529A1 (https=) |
| JP (1) | JP3471831B2 (https=) |
| KR (1) | KR100242397B1 (https=) |
| AU (1) | AU655089B2 (https=) |
| CA (1) | CA2084334A1 (https=) |
| TW (1) | TW225476B (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3471831B2 (ja) * | 1991-12-09 | 2003-12-02 | 富山化学工業株式会社 | 新規なトリアゾール誘導体およびその塩 |
| ES2062941B1 (es) * | 1993-03-15 | 1995-10-01 | Uriach & Cia Sa J | Nuevos derivados de azol activos por via oral. |
| ES2159676T3 (es) * | 1995-12-22 | 2001-10-16 | Ss Pharmaceutical Co | Derivados de triazol con actividad antimicotica e intermediarios. |
| US6002028A (en) * | 1995-12-22 | 1999-12-14 | Ss Pharmaceutical Co., Ltd. | Triazole derivative, preparation process thereof and pharmaceutical comprising the same as an effective ingredient |
| US5939448A (en) * | 1996-06-21 | 1999-08-17 | Ss Pharmaceutical Co., Ltd. | Triazole derivative or salt thereof |
| US5965188A (en) * | 1996-07-31 | 1999-10-12 | Anitox Corporation | Anti-bacterial amine derivatives |
| DK1399402T3 (da) * | 2001-06-26 | 2010-11-15 | Basilea Pharmaceutica Ag | Intermediære halophenylderivater og deres anvendelse i en fremgangsmåde til fremstilling af azolderivater |
| JP2006182765A (ja) * | 2004-11-30 | 2006-07-13 | Sumitomo Chemical Co Ltd | エポキシトリアゾール誘導体の製造方法 |
| WO2006059759A1 (ja) * | 2004-11-30 | 2006-06-08 | Sumitomo Chemical Company, Limited | エポキシトリアゾール誘導体の製造方法 |
| EP2440518B1 (de) * | 2009-06-08 | 2014-08-20 | Bayer Cropscience AG | Verfahren zur herstellung von fluoralkylnitrilen |
| US20150246898A1 (en) * | 2012-09-12 | 2015-09-03 | Dow Agrosciences Llc | Metalloenzyme inhibitor compounds |
| CN102993052B (zh) * | 2012-12-29 | 2014-07-09 | 吉首大学 | 芳基丙酰氧肟酸类尿素酶抑制剂及其合成和用途 |
| CN103012207B (zh) * | 2012-12-29 | 2015-05-27 | 吉首大学 | 二芳基丙酰-n-甲基氧肟酸类尿素酶抑制剂及其合成和用途 |
| WO2023243700A1 (ja) * | 2022-06-17 | 2023-12-21 | シンクレスト株式会社 | ジフルオロアルデヒド、エポキシ及びその誘導体 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4616027A (en) * | 1982-08-14 | 1986-10-07 | Pfizer Inc. | Antifungal 1-aryl-1-fluoroalkyl-2-(1H-1,2,4-triazol-1-yl)ethanols |
| PH19347A (en) * | 1982-09-30 | 1986-04-02 | Pfizer | Triazole derivatives,pharmaceutical composition containing same and method of use thereof |
| DE3378764D1 (en) * | 1982-09-30 | 1989-02-02 | Pfizer Ltd | Triazole anti-fungal agents |
| GB8312624D0 (en) * | 1983-05-07 | 1983-06-08 | Pfizer Ltd | Triazole antifungal agents |
| BG48681A3 (bg) * | 1982-12-14 | 1991-04-15 | Ciba - Geigy Ag | Фунгицидно средство |
| DE3461637D1 (en) * | 1983-02-16 | 1987-01-22 | Pfizer Ltd | Triazole antifungal agents |
| GB8304282D0 (en) * | 1983-02-16 | 1983-03-23 | Pfizer Ltd | Antifungal agents |
| GB8305377D0 (en) | 1983-02-25 | 1983-03-30 | Pfizer Ltd | Antifungal agents |
| US4518604A (en) * | 1983-07-25 | 1985-05-21 | Pfizer Inc. | Antifungal 1-aryl-2-(1H-1,2,4-triazol-1yl)-1-perfluoroalkylethyl halides |
| GB8322983D0 (en) * | 1983-08-26 | 1983-09-28 | Pfizer Ltd | Triazole antifungal agents |
| GB8601952D0 (en) * | 1986-01-28 | 1986-03-05 | Ici Plc | Heterocyclic compounds |
| DE3736773A1 (de) * | 1987-10-30 | 1989-05-11 | Bayer Ag | 3-(4-chlorphenyl)-2,2-dimethyl-3-hydroxy-4- (1,2,4-triazol-1-yl)-butyronitril |
| KR910700237A (ko) * | 1989-01-23 | 1991-03-14 | 리챠드 지. 워터맨 | 치환된 트리아졸, 그의 제조방법 및 살진균제로서 사용하기 위한 조성물 |
| DE59108565D1 (de) * | 1990-08-09 | 1997-04-03 | Bayer Ag | Halogenalkyl-azolyl-Derivate |
| JP3471831B2 (ja) * | 1991-12-09 | 2003-12-02 | 富山化学工業株式会社 | 新規なトリアゾール誘導体およびその塩 |
-
1992
- 1992-10-08 JP JP29396192A patent/JP3471831B2/ja not_active Expired - Fee Related
- 1992-12-02 CA CA002084334A patent/CA2084334A1/en not_active Abandoned
- 1992-12-03 AU AU29858/92A patent/AU655089B2/en not_active Ceased
- 1992-12-07 TW TW081109784A patent/TW225476B/zh active
- 1992-12-08 US US07/986,800 patent/US5366989A/en not_active Expired - Fee Related
- 1992-12-08 KR KR1019920023597A patent/KR100242397B1/ko not_active Expired - Fee Related
- 1992-12-09 EP EP92121008A patent/EP0546529A1/en not_active Ceased
-
1994
- 1994-06-17 US US08/261,952 patent/US5605921A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AU2985892A (en) | 1993-07-01 |
| JP3471831B2 (ja) | 2003-12-02 |
| CA2084334A1 (en) | 1993-06-10 |
| TW225476B (https=) | 1994-06-21 |
| EP0546529A1 (en) | 1993-06-16 |
| JPH05213906A (ja) | 1993-08-24 |
| US5366989A (en) | 1994-11-22 |
| US5605921A (en) | 1997-02-25 |
| AU655089B2 (en) | 1994-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100242397B1 (ko) | 트리아졸 유도체와 그의 염,그들의 제조방법 및 그들을 함유한 항진균제 | |
| KR100449797B1 (ko) | N-치환된 카바모일옥시알킬-아졸리움 유도체 | |
| JP2818097B2 (ja) | アゾール化合物、その製造方法及びその用途 | |
| RU2095358C1 (ru) | Производные 1,2,4-триазола или их фармацевтически приемлемые соли, фармацевтическая композиция и промежуточные соединения | |
| CN119241481A (zh) | 作为yap/taz-tead蛋白-蛋白相互作用抑制剂的联芳基衍生物 | |
| CA3003275A1 (en) | Acc inhibitors and uses thereof | |
| US20070027322A1 (en) | N-substituted carbamoyloxyalkyl-azolium derivatives | |
| CN102112453A (zh) | 新的钾通道阻断剂及其用途 | |
| JP2013519667A (ja) | 新規抗真菌性トリアゾール誘導体 | |
| HU219212B (en) | Azole compounds, pharmaceutical compositions containing them and process for the preparation of these compounds | |
| KR100252433B1 (ko) | 엔-벤질아졸륨 유도체 | |
| EP0133248B1 (en) | 1,2,4-triazol-1-yl-derivatives | |
| US4933339A (en) | (2-cyano-2-arylethyl)pyridine compounds useful in controlling fungicidal activity | |
| EP1951705A1 (en) | Novel antifungal triazole derivatives | |
| JPH02243673A (ja) | シクロプロピル置換アゾリルメチルカルビノール誘導体、その製造方法及び医薬としてのその用途 | |
| IE862169L (en) | (2-cyano-2-arylethyl) pyridines | |
| JP3050982B2 (ja) | 新規なトリアゾール誘導体およびその塩 | |
| Kidwai et al. | Discovery and development of antifungal compounds | |
| JP2887523B2 (ja) | 新規なトリアゾール誘導体およびその塩 | |
| JP2887522B2 (ja) | 新規なトリアゾール誘導体およびその塩 | |
| KR870001028B1 (ko) | 헤테로 환-치환된 알콕시카보닐메톡시이미노아세트산 및 그의 벤즈티아졸릴 티오에스테르의 제조 방법 | |
| AU726495B2 (en) | N-benzylazolium derivatives | |
| WO2003008391A1 (en) | Azole compounds as anti-fungal agents | |
| EP0613890A1 (en) | Novel triazole compound, process for preparing the same and antifungal agent containing the same | |
| EP0428106A1 (en) | Novel pyridyloxazole 2-ones useful as proteinkinase C inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
St.27 status event code: A-0-1-A10-A12-nap-PA0109 |
|
| R17-X000 | Change to representative recorded |
St.27 status event code: A-3-3-R10-R17-oth-X000 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| A201 | Request for examination | ||
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| PA0201 | Request for examination |
St.27 status event code: A-1-2-D10-D11-exm-PA0201 |
|
| R17-X000 | Change to representative recorded |
St.27 status event code: A-3-3-R10-R17-oth-X000 |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
St.27 status event code: A-1-2-D10-D21-exm-PE0902 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
St.27 status event code: A-1-2-D10-D22-exm-PE0701 |
|
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment |
St.27 status event code: A-2-4-F10-F11-exm-PR0701 |
|
| PR1002 | Payment of registration fee |
St.27 status event code: A-2-2-U10-U11-oth-PR1002 Fee payment year number: 1 |
|
| PG1601 | Publication of registration |
St.27 status event code: A-4-4-Q10-Q13-nap-PG1601 |
|
| LAPS | Lapse due to unpaid annual fee | ||
| PC1903 | Unpaid annual fee |
St.27 status event code: A-4-4-U10-U13-oth-PC1903 Not in force date: 20021111 Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE |
|
| PC1903 | Unpaid annual fee |
St.27 status event code: N-4-6-H10-H13-oth-PC1903 Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE Not in force date: 20021111 |